These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18766299)

  • 1. Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion.
    Kunadian V; Zorkun C; Gibson WJ; Nethala N; Harrigan C; Palmer AM; Ogando KJ; Biller LH; Lord EE; Williams SP; Lew ME; Ciaglo LN; Buros JL; Marble SJ; Gibson CM
    J Thromb Thrombolysis; 2009 Jan; 27(1):57-67. PubMed ID: 18766299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention.
    Pham PA; Pham PT; Pham PC; Miller JM; Pham PM; Pham SV
    Vasc Health Risk Manag; 2011; 7():551-67. PubMed ID: 21915172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major bleeding: management and risk reduction in acute coronary syndromes.
    Cavender MA; Rao SV; Ohman EM
    Expert Opin Pharmacother; 2008 Aug; 9(11):1869-83. PubMed ID: 18627326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Willis P; Voeltz MD
    Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.
    Halim SA; Rao SV
    Curr Drug Targets; 2011 Nov; 12(12):1831-5. PubMed ID: 21718235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
    Kwa AT; Rogers JH
    J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.
    Mehran R; Nikolsky E; Lansky AJ; Kirtane AJ; Kim YH; Feit F; Manoukian S; Moses JW; Ebrahimi R; Ohman EM; White HD; Pocock SJ; Dangas GD; Stone GW
    JACC Cardiovasc Interv; 2009 Aug; 2(8):748-57. PubMed ID: 19695543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
    Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML
    Circulation; 2012 Sep; 126(10):1185-93. PubMed ID: 22869839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.
    Gurbel PA; Tantry US
    Heart; 2016 Jun; 102(11):882-92. PubMed ID: 26944654
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing bleeding risk in acute coronary syndromes.
    Erdem G; Flather M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
    Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB
    Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents in acute coronary syndromes.
    Sakhuja R; Yeh RW; Bhatt DL
    Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary angioplasty in acute coronary syndromes: adjuvant drug therapy and management of the bleeding risk due to antithrombotic agents].
    Zagnoni S; Casella G; Musuraca AC; Calabrese D; Pavesi PC; Di Pasquale G
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):34S-42S. PubMed ID: 21491738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 20. Anemia in patients undergoing percutaneous coronary intervention: current issues and future directions.
    Wang TY; Rao SV
    Am J Cardiovasc Drugs; 2007; 7(4):225-33. PubMed ID: 17696564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.